About Martin Ostrowski
Form D filings for RYNE Biotechnology in 2024 list Martin Ostrowski as executive officer.
Martin Ostrowski first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Martin Ostrowski in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Martin Ostrowski works with at each company, as listed on that company's latest Form D.
RYNE Biotechnology Inc. · Form D, Mar 1, 2024
JG
Jeff Goater
Director
PF
Peter Fuhrken
Director
HF
Howard Federoff
Executive officer and director
NM
Nick Manusos
CEO and director
DF
David Fallace
Director
JJ
Jeff Jonas
Director
JY
Jonathan Yeh
Director